Status:
COMPLETED
Population Effects of Antiretroviral Therapy to Reduce HIV Transmission (PopART)
Lead Sponsor:
HIV Prevention Trials Network
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Mental Health (NIMH)
Conditions:
HIV
Eligibility:
All Genders
18-44 years
Phase:
NA
Brief Summary
PopART is a community randomized trial that is investigating whether a community-wide combination HIV prevention package including annual home-based HIV testing, active referral and the offer of immed...
Detailed Description
HIV Prevention Trials Network (HPTN) 071 (PopART) will investigate the impact on HIV incidence of universal voluntary HIV counseling and testing (with referral to care) provided to a community through...
Eligibility Criteria
Inclusion
- Population Cohort
- 18 - 44 years of age
- Able and willing to provide informed consent
- Residing within catchment area of a designated local health unit and intending to remain so for the next three years
- Residing in a randomly selected household
- Case-Control Study 1
- At least 18 years of age
- Able and willing to provide informed consent
- Resident in the cluster during the first round of testing
- Visited by a CHiP team and offered testing during the first round of home-based testing
- Case-Control Study 2
- At least 18 years of age
- Able and willing to provide informed consent
- Resident in the cluster during the first round of testing
- Tested HIV-infected in CHiP home-based testing, or HIV-infected and disclosed that they were previously diagnosed as HIV-infected to CHiP team
- Case-Control Study 3
- At least 18 years of age
- Able and willing to provide informed consent
- Resident in the cluster during the second round of testing
- Visited by a CHiP team and offered testing during the second round of home-based testing
Exclusion
- Population Cohort
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 7 2018
Estimated Enrollment :
48540 Patients enrolled
Trial Details
Trial ID
NCT01900977
Start Date
January 1 2014
End Date
July 7 2018
Last Update
August 26 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Desmund Tutu TB Centre at Stellenbosch University
Cape Town, Western Cape, South Africa, 7505
2
Zambart
Lusaka, Zambia